SERRG Featured in NGP Magazine
A great drug, a well designed protocol, excellent monitoring, and stringent human subject protection measures account the majority of what is needed for a successful clinical trial.
However, costs are skyrocketing, trial complexity is growing, and project timelines are extended each and every day. Jeff Kingsley, CEO of SERRG, Inc., explains what is needed to reign in costs, improve quality, increase speed, and amplify accuracy…
This entry was posted on Tuesday, October 9th, 2007 at 1:54 pm and is filed under Media.
Employee E-mail